New Study Highlights Gender Differences in ADHD Diagnosis
A recent study featured in European Psychiatry has found that adult women with attention-deficit/hyperactivity disorder (ADHD) often struggle with more severe symptoms and face greater challenges in daily life than men diagnosed with the same condition. The research also points out a significant delay in diagnosing ADHD in women, a factor that might explain their heightened difficulties.
This investigation came about as awareness grows regarding how ADHD manifests differently across genders. Once thought to primarily affect boys, there’s now a broader understanding that ADHD can continue into adulthood for many individuals, particularly with women frequently going undiagnosed.
Led by Ferran Mestres, researchers aimed to discern how gender and specific ADHD subtypes affect severity, the linkage to other mental health issues, and the implications for daily functioning. By exploring these dimensions, the team hoped to enhance the understanding necessary for improving diagnosis and treatment tailored to various patient demographics.
To carry out the research, 900 adults with an ADHD diagnosis from a specialized clinic at Vall d’Hebron University Hospital in Barcelona participated. Among them, just under 55 percent were male. Each participant underwent an extensive evaluation across five visits with psychiatrists and psychologists who specialize in ADHD. This thorough assessment not only confirmed their diagnoses but also clarified the type of ADHD they dealt with, which included predominantly inattentive, predominantly hyperactive-impulsive, or a combination of both.
They completed numerous validated questionnaires and assessments to evaluate symptom severity, both current and historical. Other measures addressed depression, anxiety, impulsivity, sleep quality, and how ADHD impacted everyday functioning and overall disability. The researchers then analyzed the data comparing results between genders and ADHD subtypes while exploring interactions between the two.
The insights gathered revealed striking differences between men and women. One significant finding was related to the age of diagnosis. While symptoms of ADHD usually start at a similar age for both genders, women were diagnosed much later—around 29 years old—versus 24 for men. At diagnosis, women reported more intense overall symptoms than their male counterparts.
Beyond ADHD’s core symptoms, the women in the study showed higher levels of associated mental health issues. They had elevated scores for both depression and anxiety compared to men. In terms of functioning, women experienced greater social and professional challenges and reported higher levels of disability, suggesting the disorder negatively affected their daily lives more substantially. Conversely, men were more likely to have histories of legal issues and reported higher rates of substance use, including alcohol and recreational drugs.
Silvia Amoretti, a senior researcher, shared her thoughts on the findings, emphasizing the widespread impact of ADHD while noting the limited understanding of how it affects different genders. She remarked that women often receive diagnoses far later than men, potentially leading to worse outcomes, including depression and functional impairments.
In terms of ADHD subtypes, individuals with the combined presentation—featuring both inattention and hyperactivity-impulsivity—saw more severe symptoms overall. They also showed higher rates of depression and impulsivity and were more likely to engage in substance use compared to those with the predominantly inattentive subtype.
The investigation also explored the interaction of gender and ADHD subtype but found that, for most clinical measures, the influences of gender and subtype were largely independent. However, an interesting interaction arose concerning disability; women with the combined ADHD subtype reported the highest levels of impairment among all groups studied.
The researchers suggested that biological factors, like the influence of cyclical hormonal changes on brain chemistry linked to attention and emotion regulation, could contribute to this finding. Societal expectations regarding organization and emotional control for women might also play a role, as could the accumulated stress stemming from years of untreated symptoms due to delayed diagnosis.
“Our findings indicate that while ADHD symptoms start around the same age for both genders, women are diagnosed about five years later. By that point, they often exhibit more severe symptoms and face significant functional challenges,” Amoretti noted.
This situation is concerning, as it may suggest that ADHD frequently goes unnoticed in women until it escalates into a major issue. Such insights underscore the urgent need for improved early screening and diagnostic procedures that take gender differences into account.
Professor Sandra Kooij, an independent expert, acknowledged the study’s importance, pointing out the delayed diagnosis of ADHD in women largely due to differing symptom presentations and a general lack of clinician awareness. Improvements in societal and medical awareness can facilitate earlier intervention for girls and women in need.
Though the study had some limitations, like its recruitment from a specialized clinic—which might not fully represent the broader adult ADHD population—it still provides compelling evidence regarding the unique manifestations of ADHD across genders.
Future research could benefit from a longitudinal approach to further explore these dynamics and how other factors such as socioeconomic status might intersect with gender and ADHD subtype in shaping overall outcomes.
